| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2013) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | N06AX26 |
| UNII: | 3O2K1S3WQV |
| InChI Key | YQNWZWMKLDQSAC-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H22N2S |
| Molecular Weight | 298.46 |
| AlogP | 3.86 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 15.27 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 21.0 |
| Primary Target | |
|---|---|
| 5-HT1A receptor | |
| 5-HT1B receptor | |
| 5-HT3A | |
| 5-HT7 receptor | |
| SERT |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Serotonin receptor
|
- | - | - | 10-10 | 93 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC06 neurotransmitter transporter family
|
- | 3-3 | - | - | 101 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Depressive Disorder | 4 | D003866 | ClinicalTrials |
| Depressive Disorder | 4 | D003866 | ClinicalTrials |
| Anxiety Disorders | 3 | D001008 | ClinicalTrials |
| Depressive Disorder, Major | 3 | D003865 | ClinicalTrials |
| Bipolar Disorder | 2 | D001714 | ClinicalTrials |
| Attention Deficit Disorder with Hyperactivity | 2 | D001289 | ClinicalTrials |
| Feeding and Eating Disorders | 2 | D001068 | ClinicalTrials |
| Liver Diseases | 1 | D008107 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 508233-74-7 |
| ChEBI | 76016 |
| ChEMBL | CHEMBL2104993 |
| DrugBank | DB09068 |
| DrugCentral | 4806 |
| FDA SRS | 3O2K1S3WQV |
| Guide to Pharmacology | 7351 |
| PharmGKB | PA166122595 |
| PubChem | 9966051 |
| SureChEMBL | SCHEMBL236115 |
| ZINC | ZINC000034051848 |